Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of deferasirox film-coated tablet versus dispersible tablet
2013-004167-32Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of deferasirox in Thalassaemia and myelodysplastic syndrome (MDS) (2 arms), sponsored by Novartis. Primary endpoint: Overall safety. Started Mar 2014; status: completed.
02
Drugs
deferasirox
03
Conditions
Thalassaemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on 2013-004167-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004167-32.